Commonwealth Diagnostics International
Medical Devices
Salem, Massachusetts

Overall Rank: 98
Category: Medical Devices
Category Rank: 16

Awards:

  • Top HealthTech Company of 2022

Profile

Commonwealth Diagnostics International, Inc. (CDI) is an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments.


Focused on our patient-centric principles, our cost-effective portfolio of diagnostic products results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Our expansive portfolio includes non-invasive at-home breath testing kits for Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption disorders, as well as IBSchek, a proprietary capillary collection test for Irritable Bowel Syndrome (IBS-D/M), and MyGi Health, a cloud-based healthcare platform that enables patients to manage and understand their symptoms for a range of conditions.


Founded in 2015 in Salem, Massachusetts, and operating out of our CLIA-certified laboratory and as an FDA-registered, ISO 13485-certified medical device manufacturer, we pride ourselves on our partnerships with leading health systems, hospitals, and private practices worldwide. CDI has seen a tremendous shift from point-of-care to at-home diagnostics, leading to 75% growth over the past three years. With additional equipment, technology, and staff investments, CDI stays committed to delivering an industry-leading diagnostic experience to provider partners and their patients.


Visit commdx.com


Key Products

Breath Testing for SIBO & IMO


When bacteria normally found in the large intestine become present in the small intestine, the digestive system may produce excessive hydrogen and/or methane gas, which can cause many gastrointestinal symptoms such as bloating, diarrhea, and/or constipation. This condition has historically been diagnosed as Small Intestinal Bacterial Overgrowth (SIBO) and either classified as hydrogen-related SIBO or methane-related SIBO. However, new guidelines outlining the distinction between each classification has led to the reclassification of methane-related SIBO as Intestinal Methanogen Overgrowth (IMO), since methane in the gastrointestinal tract is produced by archaea, which is actually not a bacteria.


Breath Testing for Lactose Malabsorption


When the enzyme needed to break down lactose, a sugar commonly found in dairy products, is not present, a condition called Lactose Malabsorption may occur. The lack of the enzyme allows bacteria normally found in your digestive system to produce hydrogen and/or methane gas which can cause many gastrointestinal symptoms such as bloating, diarrhea, and/or flatulence.


Breath Testing for Fructose Malabsorption


When the enzyme needed to break down Fructose, a sugar commonly found in fruit, is not present, a condition called Fructose Malabsorption may occur. The lack of the enzyme allows bacteria normally found in your digestive system to produce hydrogen and/or methane gas which can cause many gastrointestinal symptoms such as bloating, diarrhea, and/or flatulence.


Breath Testing for Sucrose Malabsorption


When the enzyme needed to break down Sucrose, or table sugar, is not present, a condition called Sucrose Malabsorption may occur. The lack of the enzyme allows bacteria normally found in your digestive system to produce hydrogen and/or methane gas which can cause many gastrointestinal symptoms such as bloating, diarrhea, and/or flatulence.


IBSchek® Capillary Collection Kit


IBSchek® Capillary Kit is designed to help patients and physicians quickly and reliably diagnose diarrhea-predominant or mixed-symptom IBS (IBS-D/M). Symptoms of this chronic ailment often occur following an incident of acute gastroenteritis (food poisoning). IBSchek is available with direct patient access, simple and safe sample collection, free shipping, and easy-to-understand results in just a few days.


MyGiHealth


Designed by industry-leading GI physicians, MyGiHealth is a cloud-based, patient-focused healthcare application that enables patients to monitor, manage, and understand their symptoms while enhancing the patients’ relationship and communication with their integrated care team, and as a recruiting tool to find highly characterized and qualified patients for clinical trials.


Customer Insights

“The transition from in-office to at-home breath testing was relatively seamless with CDI. It was very easy to order the testing online, and the results were reliably returned to me electronically. Many of my patients appreciated the ability to complete this testing at home, especially when the pandemic was at its worst. — Ziad F. Gellad, MD, MPH


 


“The implementation of breath testing has been a major improvement in patient care for our practice. Bloating is an extremely common and frustrating complaint from patients that we can now provide an answer for in many cases” — Arnab Ray. MD


 


“Breath testing has been hugely beneficial for my practice for many years. It allows me to help patients who have seen multiple doctors without finding the cause of their problems, and who continue to struggle with digestive dysfunctions.” — Aliza Cicerone, ND, FABNO


 


“It can be challenging to diagnose IBS-D and malabsorption in a busy clinical practice. Having an objective marker to diagnose and reassure the patient and provider is a great asset in my practice. It also helps me to manage the condition by using appropriate treatment. — Shashi Kumar, MD